Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00062296

First received: June 5, 2003

Last updated: August 29, 2009

Last verified: September 2004

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)